EVER vs JNJ · P/E 6.6, rev $385.9M vs P/E 17, rev $49.37B
EverQuote Inc Class A (EVER) versus Johnson & Johnson (JNJ) — a side-by-side from cached financials, not a winner call.
EverQuote Inc Class A (EVER) is a internet content & information company listed on US.
Johnson & Johnson (JNJ) is a drug manufacturers - general company listed on US. It is led by Joaquin Duato.
Latest reported EVER revenue for 2026-06-30 was $385.9M. Net income was $37.9M. EVER currently screens at market cap $683.4M and trailing P/E 6.6.
Latest reported JNJ revenue for 2026-06-28 was $49.37B. Net income was $10.77B. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
EVER currently screens at market cap $683.4M and trailing P/E 6.6. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
Not investment advice. Open the EVER and JNJ stock pages for the full models.
Not investment advice.